Intellectual Property India Publishes Patent Application for Nano-Immunomodulatory Fab, F(ab')2, Scfv, Nanobody, Vhh, Humanized, Ifn-A, Ifn-ß, Il-6, Tnf-A, Il-17,il-23, Gm-Csf, Tofacitinib, Baricitinib, Upadacitinib, Filgotinib, Curcuma Longa, Withania Somifera, Boswellia Serrata Extracts For Treatment Of Autoimmune Chronic Inflammatory Diseases

MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202611078447 A) filed by Anurag Varshney; and Shruti Varshney on June 25, 2026, for Nano-Immunomodulatory Fab, F(ab')2, Scfv, Nanobody, Vhh, Humanized, Ifn-A, Ifn-ß, Il-6, Tnf-A, Il-17,il-23, Gm-Csf, Tofacitinib, Baricitinib, Upadacitinib, Filgotinib, Curcuma Longa, Withania Somifera, Boswellia Serrata Extracts For Treatment Of Autoimmune Chronic Inflammatory Diseases.

Inventors include Anurag Varshney; and Shruti Varshney.

The application for the patent was published on August 28, 2026, under issue no. 35/2026.

Abstract: The present invention relates to a nano-immunomodulatory multi-target biologic composition and controlled-release immunotherapeut...